Immunoinformatics is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.
Market Analysis and Insights: Global Immunoinformatics Market
The global Immunoinformatics market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Immunoinformatics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Immunoinformatics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Immunoinformatics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Immunoinformatics include EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group and Compugen, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Immunoinformatics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Immunoinformatics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immunoinformatics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunoinformatics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Immunoinformatics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Immunoinformatics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including EpiVax, Novozymes Biopharma, ioGenetics, International Society of Vaccines, IMGT, Dassault Systemes, Certara, Chemical Computing Group and Compugen, etc.
By Company
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co
Segment by Type
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling
Segment by Application
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology of Immune Epitopes
Immune Epitope Database
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immunoinformatics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunoinformatics companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunoinformatics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunoinformatics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cancer Diagnosis & Therapy
1.2.3 Reverse Vaccinology
1.2.4 Immune System Modeling
1.3 Market by Application
1.3.1 Global Immunoinformatics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Allergy Prediction Databases
1.3.3 Analysis Resource Database
1.3.4 International Immunogenetics System
1.3.5 The Ontology of Immune Epitopes
1.3.6 Immune Epitope Database
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunoinformatics Market Perspective (2018-2029)
2.2 Global Immunoinformatics Growth Trends by Region
2.2.1 Immunoinformatics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immunoinformatics Historic Market Size by Region (2018-2023)
2.2.3 Immunoinformatics Forecasted Market Size by Region (2024-2029)
2.3 Immunoinformatics Market Dynamics
2.3.1 Immunoinformatics Industry Trends
2.3.2 Immunoinformatics Market Drivers
2.3.3 Immunoinformatics Market Challenges
2.3.4 Immunoinformatics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Immunoinformatics by Players
3.1.1 Global Immunoinformatics Revenue by Players (2018-2023)
3.1.2 Global Immunoinformatics Revenue Market Share by Players (2018-2023)
3.2 Global Immunoinformatics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immunoinformatics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Immunoinformatics Market Concentration Ratio
3.4.1 Global Immunoinformatics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunoinformatics Revenue in 2022
3.5 Global Key Players of Immunoinformatics Head office and Area Served
3.6 Global Key Players of Immunoinformatics, Product and Application
3.7 Global Key Players of Immunoinformatics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunoinformatics Breakdown Data by Type
4.1 Global Immunoinformatics Historic Market Size by Type (2018-2023)
4.2 Global Immunoinformatics Forecasted Market Size by Type (2024-2029)
5 Immunoinformatics Breakdown Data by Application
5.1 Global Immunoinformatics Historic Market Size by Application (2018-2023)
5.2 Global Immunoinformatics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immunoinformatics Market Size (2018-2029)
6.2 North America Immunoinformatics Market Size by Type
6.2.1 North America Immunoinformatics Market Size by Type (2018-2023)
6.2.2 North America Immunoinformatics Market Size by Type (2024-2029)
6.2.3 North America Immunoinformatics Market Share by Type (2018-2029)
6.3 North America Immunoinformatics Market Size by Application
6.3.1 North America Immunoinformatics Market Size by Application (2018-2023)
6.3.2 North America Immunoinformatics Market Size by Application (2024-2029)
6.3.3 North America Immunoinformatics Market Share by Application (2018-2029)
6.4 North America Immunoinformatics Market Size by Country
6.4.1 North America Immunoinformatics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Immunoinformatics Market Size by Country (2018-2023)
6.4.3 North America Immunoinformatics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Immunoinformatics Market Size (2018-2029)
7.2 Europe Immunoinformatics Market Size by Type
7.2.1 Europe Immunoinformatics Market Size by Type (2018-2023)
7.2.2 Europe Immunoinformatics Market Size by Type (2024-2029)
7.2.3 Europe Immunoinformatics Market Share by Type (2018-2029)
7.3 Europe Immunoinformatics Market Size by Application
7.3.1 Europe Immunoinformatics Market Size by Application (2018-2023)
7.3.2 Europe Immunoinformatics Market Size by Application (2024-2029)
7.3.3 Europe Immunoinformatics Market Share by Application (2018-2029)
7.4 Europe Immunoinformatics Market Size by Country
7.4.1 Europe Immunoinformatics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Immunoinformatics Market Size by Country (2018-2023)
7.4.3 Europe Immunoinformatics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Immunoinformatics Market Size (2018-2029)
8.2 China Immunoinformatics Market Size by Type
8.2.1 China Immunoinformatics Market Size by Type (2018-2023)
8.2.2 China Immunoinformatics Market Size by Type (2024-2029)
8.2.3 China Immunoinformatics Market Share by Type (2018-2029)
8.3 China Immunoinformatics Market Size by Application
8.3.1 China Immunoinformatics Market Size by Application (2018-2023)
8.3.2 China Immunoinformatics Market Size by Application (2024-2029)
8.3.3 China Immunoinformatics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Immunoinformatics Market Size (2018-2029)
9.2 Asia Immunoinformatics Market Size by Type
9.2.1 Asia Immunoinformatics Market Size by Type (2018-2023)
9.2.2 Asia Immunoinformatics Market Size by Type (2024-2029)
9.2.3 Asia Immunoinformatics Market Share by Type (2018-2029)
9.3 Asia Immunoinformatics Market Size by Application
9.3.1 Asia Immunoinformatics Market Size by Application (2018-2023)
9.3.2 Asia Immunoinformatics Market Size by Application (2024-2029)
9.3.3 Asia Immunoinformatics Market Share by Application (2018-2029)
9.4 Asia Immunoinformatics Market Size by Region
9.4.1 Asia Immunoinformatics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Immunoinformatics Market Size by Region (2018-2023)
9.4.3 Asia Immunoinformatics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Immunoinformatics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Immunoinformatics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immunoinformatics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Immunoinformatics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Immunoinformatics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Immunoinformatics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immunoinformatics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Immunoinformatics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Immunoinformatics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Immunoinformatics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immunoinformatics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Immunoinformatics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Immunoinformatics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 EpiVax
11.1.1 EpiVax Company Details
11.1.2 EpiVax Business Overview
11.1.3 EpiVax Immunoinformatics Introduction
11.1.4 EpiVax Revenue in Immunoinformatics Business (2018-2023)
11.1.5 EpiVax Recent Developments
11.2 Novozymes Biopharma
11.2.1 Novozymes Biopharma Company Details
11.2.2 Novozymes Biopharma Business Overview
11.2.3 Novozymes Biopharma Immunoinformatics Introduction
11.2.4 Novozymes Biopharma Revenue in Immunoinformatics Business (2018-2023)
11.2.5 Novozymes Biopharma Recent Developments
11.3 ioGenetics
11.3.1 ioGenetics Company Details
11.3.2 ioGenetics Business Overview
11.3.3 ioGenetics Immunoinformatics Introduction
11.3.4 ioGenetics Revenue in Immunoinformatics Business (2018-2023)
11.3.5 ioGenetics Recent Developments
11.4 International Society of Vaccines
11.4.1 International Society of Vaccines Company Details
11.4.2 International Society of Vaccines Business Overview
11.4.3 International Society of Vaccines Immunoinformatics Introduction
11.4.4 International Society of Vaccines Revenue in Immunoinformatics Business (2018-2023)
11.4.5 International Society of Vaccines Recent Developments
11.5 IMGT
11.5.1 IMGT Company Details
11.5.2 IMGT Business Overview
11.5.3 IMGT Immunoinformatics Introduction
11.5.4 IMGT Revenue in Immunoinformatics Business (2018-2023)
11.5.5 IMGT Recent Developments
11.6 Dassault Systemes
11.6.1 Dassault Systemes Company Details
11.6.2 Dassault Systemes Business Overview
11.6.3 Dassault Systemes Immunoinformatics Introduction
11.6.4 Dassault Systemes Revenue in Immunoinformatics Business (2018-2023)
11.6.5 Dassault Systemes Recent Developments
11.7 Certara
11.7.1 Certara Company Details
11.7.2 Certara Business Overview
11.7.3 Certara Immunoinformatics Introduction
11.7.4 Certara Revenue in Immunoinformatics Business (2018-2023)
11.7.5 Certara Recent Developments
11.8 Chemical Computing Group
11.8.1 Chemical Computing Group Company Details
11.8.2 Chemical Computing Group Business Overview
11.8.3 Chemical Computing Group Immunoinformatics Introduction
11.8.4 Chemical Computing Group Revenue in Immunoinformatics Business (2018-2023)
11.8.5 Chemical Computing Group Recent Developments
11.9 Compugen
11.9.1 Compugen Company Details
11.9.2 Compugen Business Overview
11.9.3 Compugen Immunoinformatics Introduction
11.9.4 Compugen Revenue in Immunoinformatics Business (2018-2023)
11.9.5 Compugen Recent Developments
11.10 Genedata AG
11.10.1 Genedata AG Company Details
11.10.2 Genedata AG Business Overview
11.10.3 Genedata AG Immunoinformatics Introduction
11.10.4 Genedata AG Revenue in Immunoinformatics Business (2018-2023)
11.10.5 Genedata AG Recent Developments
11.11 Insilico Biotechnology AG
11.11.1 Insilico Biotechnology AG Company Details
11.11.2 Insilico Biotechnology AG Business Overview
11.11.3 Insilico Biotechnology AG Immunoinformatics Introduction
11.11.4 Insilico Biotechnology AG Revenue in Immunoinformatics Business (2018-2023)
11.11.5 Insilico Biotechnology AG Recent Developments
11.12 Leadscope Inc
11.12.1 Leadscope Inc Company Details
11.12.2 Leadscope Inc Business Overview
11.12.3 Leadscope Inc Immunoinformatics Introduction
11.12.4 Leadscope Inc Revenue in Immunoinformatics Business (2018-2023)
11.12.5 Leadscope Inc Recent Developments
11.13 Nimbus Discovery
11.13.1 Nimbus Discovery Company Details
11.13.2 Nimbus Discovery Business Overview
11.13.3 Nimbus Discovery Immunoinformatics Introduction
11.13.4 Nimbus Discovery Revenue in Immunoinformatics Business (2018-2023)
11.13.5 Nimbus Discovery Recent Developments
11.14 Strand Life Sciences
11.14.1 Strand Life Sciences Company Details
11.14.2 Strand Life Sciences Business Overview
11.14.3 Strand Life Sciences Immunoinformatics Introduction
11.14.4 Strand Life Sciences Revenue in Immunoinformatics Business (2018-2023)
11.14.5 Strand Life Sciences Recent Developments
11.15 Schrodinger
11.15.1 Schrodinger Company Details
11.15.2 Schrodinger Business Overview
11.15.3 Schrodinger Immunoinformatics Introduction
11.15.4 Schrodinger Revenue in Immunoinformatics Business (2018-2023)
11.15.5 Schrodinger Recent Developments
11.16 Simulation Plus
11.16.1 Simulation Plus Company Details
11.16.2 Simulation Plus Business Overview
11.16.3 Simulation Plus Immunoinformatics Introduction
11.16.4 Simulation Plus Revenue in Immunoinformatics Business (2018-2023)
11.16.5 Simulation Plus Recent Developments
11.17 Rosa & Co
11.17.1 Rosa & Co Company Details
11.17.2 Rosa & Co Business Overview
11.17.3 Rosa & Co Immunoinformatics Introduction
11.17.4 Rosa & Co Revenue in Immunoinformatics Business (2018-2023)
11.17.5 Rosa & Co Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
EpiVax
Novozymes Biopharma
ioGenetics
International Society of Vaccines
IMGT
Dassault Systemes
Certara
Chemical Computing Group
Compugen
Genedata AG
Insilico Biotechnology AG
Leadscope Inc
Nimbus Discovery
Strand Life Sciences
Schrodinger
Simulation Plus
Rosa & Co
听
听
*If Applicable.
